FDA SAYS 'TELLING PEOPLE NOT TO TAKE IVERMECTIN FOR COVID-19💊💉WAS JUST A RECOMMENDATION'

Sama_El
Published on Nov 21, 2022
Source: https://www.youtube.com/@thirdrailify7629
The U.S. Food and Drug Administration (FDA) telling people to “stop” taking ivermectin for COVID-19 was informal and just a recommendation, government lawyers argued during a recent hearing.
https://archive.ph/srYyI - FDA Says Telling People Not to Take Ivermectin for COVID-19 Was Just a Recommendation
“The cited statements were not directives. They were not mandatory. They were recommendations. They said what parties should do. They said, for example, why you should not take ivermectin to treat COVID-19. They did not say you may not do it, you must not do it. They did not say it’s prohibited or it’s unlawful. They also did not say that doctors may not prescribe ivermectin,” Isaac Belfer, one of the lawyers, told the court during the Nov. 1 hearing in federal court in Texas.
“They use informal language, that is true,” he also said, adding that, “it’s conversational but not mandatory.”
The hearing was held in a case brought by three doctors who say the FDA illegally interfered with their ability to prescribe medicine to their patients when it issued statements on ivermectin, an anti-parasitic that has shown positive results in some trials against COVID-19.
Ivermectin is approved by the FDA but not for COVID-19. Drugs are commonly used for non-approved purposes in the United States; the practice is known as off-label treatment.
The FDA created a webpage in 2021 titled “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19” and later posted a link to the page on Twitter while writing: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.” A second post stated: “Hold your horses, y’all. Ivermectin may be trending, but it still isn’t authorized or approved to treat COVID-19.”
In a separate page, the FDA said: “Q: Should I take ivermectin to prevent or treat COVID-19? A: No.”
Those actions interfered with the doctors’ practice of medicine, violating the laws including the Federal Food, Drug, and Cosmetic Act, the lawsuit alleges.
It asked the court to rule the actions unlawful and bar the FDA from directing or opining as to whether ivermectin should be used to treat COVID-19.
Jared Kelson, an attorney representing the plaintiffs, told the court during the hearing that that informal claim “doesn’t explain the language they actually used: ‘Stop it. Stop it with the ivermectin.'”
The FDA’s actions “clearly convey that this is not an acceptable way to treat these patients,” he argued.
Plaintiffs in the case include Dr. Paul Marik, who began utilizing ivermectin in his COVID-19 treatment protocol in 2020 while he was chief of pulmonary and critical care medicine at Eastern Virginia Medical School and director of the intensive care unit at Sentara Norfolk General Hospital.
Read the rest at the above URL

Share Video

  • 560 x 315
  • 640 x 360
  • 853 x 480
  • 1280 x 720

Add to

Flag Video

Rate video

Rate video

DISCLAIMER

The content presented in this stream and/or video may be satirical in nature for entertainment purposes. It may contain realistic scenarios that may include themes of racism, anti-semitism, anti-LGBT sentiment and even elements such as death threats, all purely in the context of parody. In addition, this content may depict or refer to acts of violence in a satirical manner. Shock factor is a common and deliberate element used in these displays to emphasise the satirical message. By continuing to view this content, you acknowledge that you understand the satirical nature of this content, including the depiction of violence and the use of shock factor, and agree that you will not use or interpret this content outside of its intended context. Please remember that humour and satire are complex; they are not intended to belittle or demean, but to engage and challenge social norms through exaggeration. If you have any concerns about content, please feel free to engage in constructive dialogue or report issues to GTV staff.

Up next